An event held in cooperation with the Biotechnologieverbund Berlin-Brandenburg e.V. (BBB); the Paul-Ehrlich-Institut; the Central Authority of the Länder for Health Protection with regard to Medicinal Products and Medical Devices (ZLG); the German Stem Cell Network (GSCN); HealthCapital – Healthcare Industries Cluster Berlin-Brandenburg; and Berlin Partner.
28.11.2024 09:00 AM
28.11.2024 05:00 PM
Investitionsbank des Landes Brandenburg, Babelsberger Straße 21, 14473 Potsdam
bbb e.V., Paul-Ehrlich-Institut, German ZLG, GSCN, HealthCapital
Dr Ralf Sanzenbacher from the Transfusion Medicine, Cell Therapy and Tissue Preparations Section at the Paul-Ehrlich-Institut initiated this symposium in 2011. As in the past years, Dr Sanzenbacher established the theme for this year's programme, recruited speakers, and will moderate the event. The event will feature Professor Ulrike Köhl, Head of the Fraunhofer Institute for Cell Therapy and Immunology Leipzig, as the keynote speaker. She is also a professor of immuno-oncology at the Institute of Clinical Immunology at the University of Leipzig Medical Center. Ulrike Köhl has received both national and international recognition for her expertise in immunotherapies and stem cell transplantation and is a member of numerous expert committees and consortia.
Important note: English will be the official language of the event, but individual questions or topics may be addressed in German.
Participation fee: €240.00
A reduced participation fee of 50% applies for representatives of public authorities.
Please indicate your public authority affiliation in the "Remarks" (Anmerkungen) field of the registration form.
The participation fee is €40.00 for students.
Please enter your matriculation number in the "Remarks" (Anmerkungen) field when registering.
Please send any questions to the following address: k.haltermann@biotech-verbund.de
